Cannabix Delivers First Marijuana Breath Test to Major Construction Client
Event summary
- Cannabix Technologies delivered its first commercial Marijuana Breath Test (MBT) to a major construction client in the Pacific Northwest on March 19, 2026.
- The MBT detects delta-9 THC in breath within approximately four hours of use, addressing the need for recent-use detection in safety-sensitive industries.
- The test uses Cannabix’s proprietary Breath Collection Unit and Breath Cartridge technologies, analyzed via liquid chromatography-mass spectrometry (LC-MS).
- Cannabix partners with Omega Laboratories Inc. for laboratory analysis, leveraging over 25 years of forensic drug testing expertise.
The big picture
Cannabix’s MBT addresses a critical gap in workplace safety by providing a non-invasive, recent-use detection method for cannabis. This is particularly relevant in high-risk industries like construction, where traditional drug testing methods fail to distinguish between recent and historical use. The strategic partnership with Omega Laboratories Inc. enhances the credibility and scalability of the MBT, positioning it as a potential standard for impairment-related testing across multiple safety-critical sectors.
What we're watching
- Market Adoption
- How quickly Cannabix can secure additional contracts in safety-sensitive industries like construction and transportation.
- Regulatory Compliance
- Whether the MBT can navigate evolving legal frameworks for cannabis testing in various jurisdictions.
- Technological Scalability
- The pace at which Cannabix can scale production to meet growing demand for the MBT.
Related topics